"Chorioallantoic Membrane" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A highly vascularized extra-embryonic membrane, formed by the fusion of the CHORION and the ALLANTOIS. It is mostly found in BIRDS and REPTILES. It serves as a model for studying tumor or cell biology, such as angiogenesis and TISSUE TRANSPLANTATION.
| Descriptor ID |
D049033
|
| MeSH Number(s) |
A10.615.284.375 A13.350.575 A16.331.400
|
| Concept/Terms |
Chorioallantoic Membrane- Chorioallantoic Membrane
- Chorioallantoic Membranes
- Membrane, Chorioallantoic
- Membranes, Chorioallantoic
|
Below are MeSH descriptors whose meaning is more general than "Chorioallantoic Membrane".
Below are MeSH descriptors whose meaning is more specific than "Chorioallantoic Membrane".
This graph shows the total number of publications written about "Chorioallantoic Membrane" by people in this website by year, and whether "Chorioallantoic Membrane" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chorioallantoic Membrane" by people in Profiles.
-
Van Tubergen EA, Banerjee R, Liu M, Vander Broek R, Light E, Kuo S, Feinberg SE, Willis AL, Wolf G, Carey T, Bradford C, Prince M, Worden FP, Kirkwood KL, D'Silva NJ. Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6. Clin Cancer Res. 2013 Mar 01; 19(5):1169-79.
-
Movahedi B, Gysemans C, Jacobs-Tulleneers-Thevissen D, Mathieu C, Pipeleers D. Pancreatic duct cells in human islet cell preparations are a source of angiogenic cytokines interleukin-8 and vascular endothelial growth factor. Diabetes. 2008 Aug; 57(8):2128-36.